Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Food entities : Abbvie inc. save search
U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients
Published: 2024-03-22 (Crawled : 19:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
| Email alert
Add to watchlist
elahere drug approval food cancer grants
U.S. Food and Drug Administration (FDA) Grants Priority Review of Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma (FL)
Published: 2024-02-27 (Crawled : 13:30) - biospace.com/
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: 0.0%
epkinly drug review food grants
AbbVie Announces U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the Treatment of Relapsed/Refractory Follicular Lymphoma
Published: 2023-11-27 (Crawled : 12:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
epkinly drug abbvie food treatment
EPKINLY™ (epcoritamab-bysp) Approved by U.S. Food and Drug Administration as the First and Only Bispecific Antibody to Treat Adults with Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
Published: 2023-05-19 (Crawled : 16:00) - globenewswire.com
GNMSF | News | $290.34 0.23% 3.83% 1.2K
|
Health Technology
|
| O: 0.61%
H: 1.26%
C: 1.24%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 0.29%
H: 1.35%
C: 0.87%
GMAB | News | $28.47 -0.32% -0.32% 430K
|
Health Technology
|
| O: 0.54%
H: 2.0%
C: 1.81%
drug antibody approved food
Genmab Announces U.S. Food and Drug Administration Granted Orphan-Drug Designation to Epcoritamab (DuoBody®-CD3xCD20) in Follicular Lymphoma
Published: 2022-03-08 (Crawled : 13:00) - globenewswire.com
GNMSF | News | $290.34 0.23% 3.83% 1.2K
|
Health Technology
|
| O: -0.14%
H: 5.36%
C: 5.36%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 0.29%
H: 0.6%
C: -1.24%
GMAB | News | $28.47 -0.32% -0.32% 430K
|
Health Technology
|
| O: -0.3%
H: 3.38%
C: 0.32%
cd20 duobody drug granted drug designation food grant designation
U.S. Food and Drug Administration Approves VUITY™ (pilocarpine HCI ophthalmic solution) 1.25%, the First and Only Eye Drop to Treat Presbyopia (Age-Related Blurry Near Vision)
Published: 2021-10-29 (Crawled : 22:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
| Email alert
Add to watchlist
food eye drop drug presbyopia
Global Atopic Dermatitis Drugs Market Report 2021: Rising Incident of Food Allergies Intensifying Atopic Dermatitis - Forecast to 2026
Published: 2021-08-19 (Crawled : 23:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -0.56%
H: 0.87%
C: 0.7%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: -0.17%
H: 0.67%
C: 0.26%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
BMY | $48.86 -0.27% 0.98% 14M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
BHC | $8.56 0.35% 0.12% 2M
|
Health Technology
|
| O: 0.04%
H: 1.71%
C: 0.18%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 0.14%
H: 1.16%
C: 0.61%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
food dermatitis drug atopic dermatitis
Foodservice Disposables Market Featuring Amcor Plc and Anchor Packaging Inc. | Technavio
Published: 2021-07-08 (Crawled : 03:00) - prnewswire.com
AMCR | $9.06 0.89% 0.88% 4.3M
|
Process Industries
|
| O: -0.87%
H: 0.48%
C: -0.52%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: -0.85%
H: 0.91%
C: 0.51%
food
Global Allergy Treatment Markets, 2020-2021 & Forecast to 2028: Increasing Adoption of Immunotherapy in Allergy Treatment & Developments in Food Allergy Treatments
Published: 2021-04-30 (Crawled : 19:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
| Email alert
Add to watchlist
food treatment immunotherapy therapy
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.